Affordable Access

Access to the full text

Hydrogen inhibits endometrial cancer growth via a ROS/NLRP3/caspase-1/GSDMD-mediated pyroptotic pathway

  • Yang, Ye1
  • Liu, Ping Yin2
  • Bao, Wei1
  • Chen, Song Jun3
  • Wu, Fang Su1
  • Zhu, Ping Ya1
  • 1 Shanghai Jiao Tong University School of Medicine, 85 Wujin Road, Hongkou, Shanghai, 200080, People’s Republic of China , Shanghai (China)
  • 2 Shanghai General Hospital of Nanjing Medical University, 85 Wujin Road, Hongkou, Shanghai, 200080, People’s Republic of China , Shanghai (China)
  • 3 Shanghai Jiaotong University, 800 Dongchuan Road, Biomedical Research Institute Building, Minhang, Shanghai, 200241, People’s Republic of China , Shanghai (China)
Published Article
BMC Cancer
Springer (Biomed Central Ltd.)
Publication Date
Jan 10, 2020
DOI: 10.1186/s12885-019-6491-6
Springer Nature


BackgroundPyroptosis belongs to a novel inflammatory programmed cell death pathway, with the possible prognosis of endometrial cancer related to the terminal protein GSDMD. Hydrogen exerts a biphasic effect on cancer by promoting tumor cell death and protecting normal cells, which might initiate GSDMD pathway-mediated pyroptosis.MethodsWe performed immunohistochemical staining and western immunoblotting analysis to observe expression of NLRP3, caspase-1, and GSDMD in human and xenograft mice endometrial cancer tissue and cell lines. We investigated treatment with hydrogen could boost ROS accumulation in endometrial cancer cells by intracellular and mitochondrial sources. GSDMD shRNA lentivirus was used to transfect endometrial cancer cells to investigate the function of GSDMD protein in pyroptosis. Propidium iodide (PI) staining, TUNEL assay, measurement of lactate dehydrogenase (LDH) release and IL-1β ELISA were used to analysis pyroptosis between hydrogen-supplemented or normal culture medium. We conducted in vivo human endometrial tumor xenograft mice model to observe anti-tumor effect in hydrogen supplementation.ResultsWe observed overexpression of NLRP3, caspase-1, and GSDMD in human endometrial cancer and cell lines by IHC and western immunoblotting. Hydrogen pretreatment upregulated ROS and the expression of pyroptosis-related proteins, and increased the number of PI- and TUNEL-positive cells, as well as the release of LDH and IL-1β, however, GSDMD depletion reduced their release. We further demonstrated that hydrogen supplementation in mice was sufficient for the anti-tumor effect to inhibit xenograft volume and weight of endometrial tumors, as mice subjected to hydrogen-rich water displayed decreased radiance. Tumor tissue sections in the HRW groups presented moderate-to-strong positive expression of NLRP3, caspase-1 and GSDMD. Hydrogen attenuated tumor volume and weight in a xenograft mouse model though the pyroptotic pathway.ConclusionsThis study extended our original analysis of the ability of hydrogen to stimulate NLRP3 inflammasome/GSDMD activation in pyroptosis and revealed possible mechanism (s) for improvement of anti-tumor effects in the clinical management of endometrial cancer.

Report this publication


Seen <100 times